Published in J Mol Biol on August 25, 1995
The DegP and DegQ periplasmic endoproteases of Escherichia coli: specificity for cleavage sites and substrate conformation. J Bacteriol (1996) 1.62
Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system. Microbiol Mol Biol Rev (2012) 1.11
Mutations in toxR and toxS that separate transcriptional activation from DNA binding at the cholera toxin gene promoter. J Bacteriol (1998) 0.99
Role of native-state topology in the stabilization of intracellular antibodies. Biophys J (2001) 0.79
The gapped duplex DNA approach to oligonucleotide-directed mutation construction. Nucleic Acids Res (1984) 8.30
Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of E. coli. Cell (1984) 7.26
High-pressure liquid chromatography in polynucleotide synthesis. Biochemistry (1978) 5.98
Directed mutagenesis of DNA cloned in filamentous phage: influence of hemimethylated GATC sites on marker recovery from restriction fragments. Nucleic Acids Res (1982) 5.72
Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res (1989) 3.99
DNA mismatch-repair in Escherichia coli counteracting the hydrolytic deamination of 5-methyl-cytosine residues. EMBO J (1987) 2.91
The sequence of IS4. Mol Gen Genet (1981) 2.80
Mismatches in DNA double strands: thermodynamic parameters and their correlation to repair efficiencies. Nucleic Acids Res (1986) 2.73
The vsr gene product of E. coli K-12 is a strand- and sequence-specific DNA mismatch endonuclease. Nature (1991) 2.36
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia (2004) 2.08
Close vicinity of IS1 integration sites in the leader sequence of the gal operon of E. coli. Mol Gen Genet (1979) 2.07
Oligonucleotide-directed construction of mutations via gapped duplex DNA. Methods Enzymol (1987) 1.90
Dimerisation of the glycophorin A transmembrane segment in membranes probed with the ToxR transcription activator. J Mol Biol (1996) 1.86
Characterization of two mutations in the Escherichia coli galE gene inactivating the second galactose operator and comparative studies of repressor binding. EMBO J (1983) 1.72
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study. Leukemia (2013) 1.71
1.7 A structure of the stabilized REIv mutant T39K. Application of local NCS restraints. Acta Crystallogr D Biol Crystallogr (1999) 1.53
Statistical evaluation and biological interpretation of non-random abundance in the E. coli K-12 genome of tetra- and pentanucleotide sequences related to VSP DNA mismatch repair. Nucleic Acids Res (1992) 1.50
Resolution of Holliday structures by endonuclease VII as observed in interactions with cruciform DNA. Cold Spring Harb Symp Quant Biol (1984) 1.45
Studies on transposition mechanisms and specificity of IS4. Cold Spring Harb Symp Quant Biol (1981) 1.35
Total synthesis of a tyrosine suppressor transfer RNA gene. XVI. Enzymatic joinings to form the total 207-base pair-long DNA. J Biol Chem (1979) 1.33
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia (2012) 1.33
The upstream operator of the Escherichia coli galactose operon is sufficient for repression of transcription initiated at the cyclic AMP-stimulated promoter. EMBO J (1986) 1.27
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study. Leukemia (2012) 1.27
Substrate preferences of Vsr DNA mismatch endonuclease and their consequences for the evolution of the Escherichia coli K-12 genome. J Mol Biol (1995) 1.24
The Escherichia coli MutL protein stimulates binding of Vsr and MutS to heteroduplex DNA. Nucleic Acids Res (1998) 1.24
RNA polymerase and gal repressor bind simultaneously and with DNA bending to the control region of the Escherichia coli galactose operon. EMBO J (1989) 1.24
Nucleotide sequence of the dcm locus of Escherichia coli K12. Nucleic Acids Res (1989) 1.19
Unusual properties of promoter-up mutations in the Escherichia coli galactose operon and evidence suggesting RNA polymerase-induced DNA bending. EMBO J (1987) 1.15
A synthetic tyrosine suppressor tRNA gene with an altered promoter sequence. Its cloning and relative expression in vivo. J Biol Chem (1979) 1.08
Use of the lipophilic tert-butyldiphenylsilyl protecting group in synthesis and rapid separation of polynucleotides. Biochemistry (1978) 1.06
Quantitative determination of 5-methylcytosine in DNA by reverse-phase high-performance liquid chromatography. Anal Biochem (1983) 1.06
Studies on polynucleotides. CXLIII. A rapid and convenient method for the synthesis of deoxyribooligonucleotides carrying 5'-phosphate end groups using a new protecting group. J Am Chem Soc (1976) 1.05
Truncated forms of Escherichia coli lactose permease: models for study of biosynthesis and membrane insertion. J Bacteriol (1988) 1.04
Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol (2014) 1.02
Integration specificity of an artificial kanamycin transposon constructed by the in vitro insertion of an internal Tn5 fragment into IS2. Mol Gen Genet (1981) 1.02
The role of Glu73 of barnase in catalysis and the binding of barstar. J Mol Biol (1997) 0.98
Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur J Neurosci (2003) 0.98
[Sonography of the salivary glands]. Ultraschall Med (1993) 0.94
Sequence-specific and mechanism-based crosslinking of Dcm DNA cytosine-C5 methyltransferase of E. coli K-12 to synthetic oligonucleotides containing 5-fluoro-2'-deoxycytidine. Nucleic Acids Res (1993) 0.94
Dimerization of Bence Jones proteins: linking the rate of transcription from an Escherichia coli promoter to the association constant of REIV. Biol Chem Hoppe Seyler (1994) 0.94
Fast quantitative assay of sequence-specific endonuclease activity based on DNA sequencer technology. Biol Chem Hoppe Seyler (1992) 0.92
Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain. Fold Des (1996) 0.90
Inhibition of tyrosine sulfation in the trans-Golgi retards the transport of a constitutively secreted protein to the cell surface. J Cell Biol (1988) 0.90
General mutagenesis/gene expression procedure for the construction of variant immunoglobulin domains in Escherichia coli. Production of the Bence-Jones protein REIv via fusion to beta-lactamase. J Mol Biol (1992) 0.89
ToxR co-operative interactions are not modulated by environmental conditions or periplasmic domain conformation. Mol Microbiol (1999) 0.89
Improved enzymatic in vitro reactions in the gapped duplex DNA approach to oligonucleotide-directed construction of mutations. Nucleic Acids Res (1988) 0.89
Chemical synthesis of 2'-deoxyoligonucleotides containing 5-fluoro-2'-deoxycytidine. Nucleic Acids Res (1992) 0.87
Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav (2002) 0.86
Improved results in acute appendicitis care following areawide review. Med Decis Making (1984) 0.85
Unaltered radial maze performance and brain acetylcholine of the endothelial nitric oxide synthase knockout mouse. Neuroscience (2001) 0.83
High-yield production of bacteriorhodopsin via expression of a synthetic gene in Escherichia coli. Eur J Biochem (1993) 0.82
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia (2016) 0.81
Production of the immunoglobulin variable domain REIv via a fusion protein synthesized and secreted by Staphylococcus carnosus. Biol Chem Hoppe Seyler (1994) 0.81
Total synthesis of a tyrosine suppressor transfer RNA gene. XIV. Chemical synthesis of oligonucleotide segments corresponding to the terminal regions. J Biol Chem (1979) 0.80
Phasduction--a simplified protocol for oligonucleotide-directed mutagenesis by the gapped duplex DNA method. Nucleic Acids Res (1989) 0.80
Studies with IS1 and IS4. Cold Spring Harb Symp Quant Biol (1979) 0.79
Studies of the protein synthesis system in the brain cortex during global ischemia and reperfusion. Resuscitation (1993) 0.78
A soluble immunoglobulin variable domain without a disulfide bridge: construction, accumulation in the cytoplasm of E. coli, purification and physicochemical characterization. Biol Chem Hoppe Seyler (1994) 0.78
Properties of bacteriorhodopsin derivatives constructed by insertion of an exogenous epitope into extra-membrane loops. EMBO J (1993) 0.78
Statistical evidence for a biochemical pathway of natural, sequence-targeted G/C to C/G transversion mutagenesis in Haemophilus influenzae Rd. Nucleic Acids Res (1996) 0.78
X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain. Fold Des (1997) 0.78
High-frequency oscillation in the hippocampus of the behaving rat and its modulation by the histaminergic system. Hippocampus (2003) 0.77
Evidence for anatomical specificity for the reinforcing effects of SP in the nucleus basalis magnocellularis. Neuroreport (1998) 0.76
Peptide production by a combination of gene expression, chemical synthesis, and protease-catalyzed conversion. Int J Pept Protein Res (1993) 0.76
Instantaneous diastolic pressure-flow relationship in arterial coronary bypass grafts. Eur J Anaesthesiol (2006) 0.76
Comparison of intra-accumbens injection of histamine with histamine H1-receptor antagonist chlorpheniramine in effects on reinforcement and memory parameters. Behav Brain Res (2001) 0.76
Dissociation between anxiolytic and hypomnestic effects for combined extracts of zingiber officinale and ginkgo biloba, as opposed to diazepam. Pharmacol Biochem Behav (1998) 0.76
Occupational exposure to amorphous silica dust and pulmonary function. Br J Ind Med (1990) 0.76
Selecting highly structure-specific antibodies using structured synthetic mimics of the cystine knot protein sclerostin. Protein Eng Des Sel (2012) 0.76
Chronic administration of neurokinin SP improves maze performance in aged Rattus norvegicus. Behav Neural Biol (1994) 0.76
A phage-based system to select multiple protein-protein interactions simultaneously from combinatorial libraries. FEBS Lett (1998) 0.75
[Inhibition of degranulation of human basophils by calcium antagonists]. J Pharmacol (1986) 0.75
[Experiences with the treatment of combustion]. Z Arztl Fortbild (Jena) (1972) 0.75
Facilitation of learning following injection of the chondroitin sulfate proteoglycan biglycan into the vicinity of the nucleus basalis magnocellularis. Behav Brain Res (1995) 0.75
Superconductivity and the upper critical field in the chiral noncentrosymmetric superconductor NbRhB. J Phys Condens Matter (2019) 0.75
Properties of bacteriorhodopsin derivatives constructed by insertion of an exogenous epitope into extra-membrane loops. EMBO J (1994) 0.75
Rush hyposensitisation for allergy to seminal plasma. Lancet (1984) 0.75
Quantum physics, organic chemistry and the material nature of mutation--60 years later. Biol Chem Hoppe Seyler (1995) 0.75
[Esters of nucleoside-5'-carboxylic acids as model compounds for conformational analysis of nucleosides and nucleotides]. Chem Ber (1972) 0.75
Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer. Onkologie (2004) 0.75
Total synthesis of a tyrosine suppressor tRNA gene. XV. Synthesis of the promoter region. J Biol Chem (1979) 0.75
Two-chain bacteriorhodopsin synthesized by Schizosaccharomyces pombe. Biol Chem Hoppe Seyler (1994) 0.75
Normal values for the various 17-oxosteroids, pregnanes and testosterone excreted in the urine of healthy boys and girsl. Z Klin Chem Klin Biochem (1970) 0.75
Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats. Neuroscience (1994) 0.75